Table 2.
Patients, n | Patients baseline | Patients follow-up | p-value Patients baseline vs. follow-up |
Controls, n | Controls baseline | p-value Patients baseline vs. controls |
|
---|---|---|---|---|---|---|---|
LA, mm/m2 | 380 | 20.4 (3.1) | 20.6 (3.1) | ns | 183 | 20.8 (4.0) | ns |
LVEDV, mL/m2 | 371 | 46.1 (13.1) | 46.5 (12.0) | < 0.05 | 180 | 48.8 (11.3) | < 0.01 |
LV mass, g/m2 | 324 | 101.8 (30.3) | 101.7 (26.9) | ns | 174 | 94.5 (29.9) | < 0.001 |
LVEF, % | 370 | 52.0 (10.5) | 53.0 (11.0) | ns | 180 | 57.0 (9.0) | < 0.001 |
MAPSE, mm | 370 | 12.0 (2.0) | 12.0 (2.0) | ns | 184 | 12.3 (2.3) | ns |
E/é | 378 | 11.9 (4.5) | 13.3 (4.9) | < 0.001 | 183 | 10.3 (4.1) | < 0.001 |
Data are presented as median and (interquartile range)
LA LVEDV and LV mass are indexed by body surface area, ns not significant, LA left atrium, LVEDV left ventricular end-diastolic volume, LV left ventricle, LVEF left ventricular ejection fraction, MAPSE mitral annular plane systolic excursion, E transmitral E-wave velocity, eʹ early diastolic mitral annulus velocity